Cap Nimodipine in the Treatment of Cerebrovascular Disease:A Double-Blind Placebo-Controlled Trial
- VernacularTitle:尼莫地平胶囊治疗脑血管病的双盲安慰剂对照研究
- Author:
Yong PENG
;
Xiaohong ZI
;
Zhi SONG
- Publication Type:Journal Article
- Keywords:
Nimodipine;
Cerebrovascular, disease;
A double blind placebo controlled trial
- From:
Journal of Chinese Physician
2001;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of Cap Nimodipine on the treatment of three kinds of cerebrovascular disease included acute ischemic cerebrovascular disease(AICVD),subarachroid hemorrahage(SAH),and multiple infarct dementia(MID).Method 103 cases were orally given cap nimodipine 30mg tid/d ,for 18 monthes. The efficacy was assessed by a double-blind placebo-controlled trial.Results ⑴ AICVD treating group comparing to placebo group, there was significant difference in effective rate,(P0 1).⑵SAH treating group compared with placebo group,we revealed that the cerebrovascular system (CVS) event rate and death rate decreased markedly (P
